FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling
出版年份 2016 全文链接
标题
FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling
作者
关键词
-
出版物
HEPATOLOGY
Volume 63, Issue 6, Pages 1914-1927
出版商
Wiley
发表日期
2016-02-09
DOI
10.1002/hep.28496
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma
- (2014) Shu-Bin Gao et al. JOURNAL OF HEPATOLOGY
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation
- (2012) Holly K. Bryan et al. BIOCHEMICAL PHARMACOLOGY
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Regulation of neuroblastoma differentiation by forkhead transcription factors FOXO1/3/4 through the receptor tyrosine kinase PDGFRA
- (2012) Y. Mei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of cell cycle progression by forkhead transcription factor FOXO3 through its binding partner DNA replication factor Cdt1
- (2012) Y. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TRIM39 regulates cell cycle progression and DNA damage responses via stabilizing p21
- (2012) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- AKT/FOXO Signaling Enforces Reversible Differentiation Blockade in Myeloid Leukemias
- (2011) Stephen M. Sykes et al. CELL
- TNF Mediates the Sustained Activation of Nrf2 in Human Monocytes
- (2011) S. A. Rushworth et al. JOURNAL OF IMMUNOLOGY
- Cholangiocarcinoma—controversies and challenges
- (2011) Tushar Patel Nature Reviews Gastroenterology & Hepatology
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
- (2011) D. Ren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
- (2010) T. Jiang et al. CANCER RESEARCH
- Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features
- (2010) L. M. Solis et al. CLINICAL CANCER RESEARCH
- Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth
- (2010) P. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- FoxOs Cooperatively Regulate Diverse Pathways Governing Neural Stem Cell Homeostasis
- (2009) Ji-hye Paik et al. Cell Stem Cell
- FOXO3a-dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation
- (2009) Y. Mei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
- (2008) Tatsuhiro Shibata et al. GASTROENTEROLOGY
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
- (2008) Jer-Yen Yang et al. NATURE CELL BIOLOGY
- Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
- (2008) S.A. Khan et al. HPB
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now